Company / Inventory
Lexaria Bioscience Corp. Inventory History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$38.4K
FY2022
5-year range
$29.6K / $38.4K
FY2018-FY2022
Trend
+29.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2022 after 2 years of decline, reaching $38,418.
Based on SEC 10-K filings.
$38,418 in FY2022 with a 5-year CAGR of -10.6%.
Declined from $116,871 to $38,418 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -32.9%
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.6%, indicating a declining trend.
- In FY2022, inventory increased 29.6% year-over-year.
- Peak inventory was recorded in FY2015.
- Lowest inventory in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $38.4K | +29.6% |
| FY2021 | $29.6K | -74.6% |
| FY2020 | $116.9K | -8.3% |
| FY2019 | $127.4K | +89.7% |
| FY2017 | $67.2K | -50.1% |
| FY2016 | $134.7K | -19.8% |
| FY2015 | $168.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026